SUBSCRIBE
SUBSCRIBE
News   Business

SciClone Pharmaceuticals, Inc. Q3 Tops Estimates, Raises ’09 View

November 9, 2009 | 
1 min read

Bookmark and Share

Reuters -- SciClone Pharmaceuticals Inc (SCLN.O) posted a better-than-expected quarterly profit on strong sales of its hepatitis B treatment and lower research and development expenses, and raised its 2009 forecast.

Earnings
MORE ON THIS TOPIC
Podcast
RFK Jr. Advances, Q4 Earnings Roll Out and a Non-Opioid Pain Drug Hits the Market
February 5, 2025
 · 
1 min read
 · 
Heather McKenzie
Illustration of two hands shaking while another hand gently grips a wrist
Collaboration
The Top 7 Biopharma Licensing Deals of 2024
February 5, 2025
 · 
8 min read
 · 
Tristan Manalac
Illustration of a computer choosing from a display
Opinion
Pharma M&A Uptick Ushers in a New Era of Data Integration
February 5, 2025
 · 
4 min read
 · 
Raj Indupuri
Brussels, Belgium. 21st December 2020. Exterior view of Pfizer Pharmaceutical company's offices.
Earnings
Pfizer Eyes Deals up to $15B, With ‘Fruitful’ China Discussions Ongoing
February 4, 2025
 · 
4 min read
 · 
Annalee Armstrong